149 related articles for article (PubMed ID: 15958625)
1. Validation of genomics-based prognostic tests in malignant pleural mesothelioma.
Gordon GJ; Rockwell GN; Godfrey PA; Jensen RV; Glickman JN; Yeap BY; Richards WG; Sugarbaker DJ; Bueno R
Clin Cancer Res; 2005 Jun; 11(12):4406-14. PubMed ID: 15958625
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.
Suraokar MB; Nunez MI; Diao L; Chow CW; Kim D; Behrens C; Lin H; Lee S; Raso G; Moran C; Rice D; Mehran R; Lee JJ; Pass HI; Wang J; Momin AA; James BP; Corvalan A; Coombes K; Tsao A; Wistuba II
Ann Oncol; 2014 Jun; 25(6):1184-92. PubMed ID: 24669013
[TBL] [Abstract][Full Text] [Related]
3. Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma.
Gordon GJ; Dong L; Yeap BY; Richards WG; Glickman JN; Edenfield H; Mani M; Colquitt R; Maulik G; Van Oss B; Sugarbaker DJ; Bueno R
J Natl Cancer Inst; 2009 May; 101(9):678-86. PubMed ID: 19401544
[TBL] [Abstract][Full Text] [Related]
4. Using gene expression ratios to predict outcome among patients with mesothelioma.
Gordon GJ; Jensen RV; Hsiao LL; Gullans SR; Blumenstock JE; Richards WG; Jaklitsch MT; Sugarbaker DJ; Bueno R
J Natl Cancer Inst; 2003 Apr; 95(8):598-605. PubMed ID: 12697852
[TBL] [Abstract][Full Text] [Related]
5. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.
López-Ríos F; Chuai S; Flores R; Shimizu S; Ohno T; Wakahara K; Illei PB; Hussain S; Krug L; Zakowski MF; Rusch V; Olshen AB; Ladanyi M
Cancer Res; 2006 Mar; 66(6):2970-9. PubMed ID: 16540645
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs dysregulation in human malignant pleural mesothelioma.
Balatti V; Maniero S; Ferracin M; Veronese A; Negrini M; Ferrocci G; Martini F; Tognon MG
J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.
Gordon GJ; Rockwell GN; Jensen RV; Rheinwald JG; Glickman JN; Aronson JP; Pottorf BJ; Nitz MD; Richards WG; Sugarbaker DJ; Bueno R
Am J Pathol; 2005 Jun; 166(6):1827-40. PubMed ID: 15920167
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.
Ohta Y; Shridhar V; Kalemkerian GP; Bright RK; Watanabe Y; Pass HI
Cancer; 1999 Jun; 85(12):2570-6. PubMed ID: 10375104
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients.
Bahnassy AA; Zekri AR; Abou-Bakr AA; El-Deftar MM; El-Bastawisy A; Sakr MA; El-Sherif GM; Gaafar RM
Exp Mol Pathol; 2012 Aug; 93(1):154-61. PubMed ID: 22504106
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
[TBL] [Abstract][Full Text] [Related]
12. Kinesin family members KIF11 and KIF23 as potential therapeutic targets in malignant pleural mesothelioma.
Kato T; Lee D; Wu L; Patel P; Young AJ; Wada H; Hu HP; Ujiie H; Kaji M; Kano S; Matsuge S; Domen H; Kaga K; Matsui Y; Kanno H; Hatanaka Y; Hatanaka KC; Matsuno Y; de Perrot M; Yasufuku K
Int J Oncol; 2016 Aug; 49(2):448-56. PubMed ID: 27279560
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.
Schramm A; Opitz I; Thies S; Seifert B; Moch H; Weder W; Soltermann A
Eur J Cardiothorac Surg; 2010 Mar; 37(3):566-72. PubMed ID: 19781955
[TBL] [Abstract][Full Text] [Related]
14. Cell protection, resistance and invasiveness of two malignant mesotheliomas as assessed by 10K-microarray.
Mohr S; Keith G; Galateau-Salle F; Icard P; Rihn BH
Biochim Biophys Acta; 2004 Jan; 1688(1):43-60. PubMed ID: 14732480
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin.
Zucali PA; Giovannetti E; Destro A; Mencoboni M; Ceresoli GL; Gianoncelli L; Lorenzi E; De Vincenzo F; Simonelli M; Perrino M; Bruzzone A; Thunnissen E; Tunesi G; Giordano L; Roncalli M; Peters GJ; Santoro A
Clin Cancer Res; 2011 Apr; 17(8):2581-90. PubMed ID: 21262916
[TBL] [Abstract][Full Text] [Related]
16. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
Dong L; Jensen RV; De Rienzo A; Gordon GJ; Xu Y; Sugarbaker DJ; Bueno R
BMC Med Genet; 2009 Dec; 10():149. PubMed ID: 20043850
[TBL] [Abstract][Full Text] [Related]
17. Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.
De Rienzo A; Richards WG; Yeap BY; Coleman MH; Sugarbaker PE; Chirieac LR; Wang YE; Quackenbush J; Jensen RV; Bueno R
Clin Cancer Res; 2013 May; 19(9):2493-502. PubMed ID: 23493352
[TBL] [Abstract][Full Text] [Related]
18. Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up.
Destro A; Ceresoli GL; Baryshnikova E; Garassino I; Zucali PA; De Vincenzo F; Bianchi P; Morenghi E; Testori A; Alloisio M; Santoro A; Roncalli M
Lung Cancer; 2008 Mar; 59(3):369-76. PubMed ID: 17920725
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling identifies matriptase overexpression in malignant mesothelioma.
Hoang CD; D'Cunha J; Kratzke MG; Casmey CE; Frizelle SP; Maddaus MA; Kratzke RA
Chest; 2004 May; 125(5):1843-52. PubMed ID: 15136399
[TBL] [Abstract][Full Text] [Related]
20. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.
Gordon GJ; Jensen RV; Hsiao LL; Gullans SR; Blumenstock JE; Ramaswamy S; Richards WG; Sugarbaker DJ; Bueno R
Cancer Res; 2002 Sep; 62(17):4963-7. PubMed ID: 12208747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
